Himadri Speciality Chemical Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
HSCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Himadri Speciality Chemical has filed a quarterly compliance statement under SEBI Regulation 32 regarding the use of proceeds from equity shares allotted on exercise of warrants issued on a preferential basis. The company informed the exchanges that no warrant holders applied to convert their warrants into equity shares during the quarter ended 30 June 2025. As a result, the deviation/variation statement is not applicable for this quarter. The company also confirmed that proceeds raised in earlier quarters were fully utilised for the purposes stated in the Postal Ballot Notice dated 19 April 2024, with no deviation or variation in their use.
This is a routine compliance filing with no material impact on shareholders. It confirms that warrant holders did not exercise their conversion option in Q1 FY26, meaning no fresh equity dilution occurred, and that previously raised funds were used as intended with no misuse.